Report Fugitive

Pablo Manuel FERNANDEZ

Summary of OCI Investigation:

Between December 2002 and March 2003, Pablo Manuel FERNANDEZ was involved in a two pronged illegal scheme to sell and distribute counterfeit and diverted pharmaceutical drugs. First, FERNANDEZ and his conspirators bought genuine Lipitor intended for distribution in South America and illegally imported it into the United States. Second, FERNANDEZ and his conspirators bought and shipped equipment and chemicals to Costa Rica and Honduras to manufacture counterfeit Lipitor which they then illegally smuggled into the United States. The conspirators commingled the illegally imported Lipitor with the counterfeit Lipitor and sold it in the United States. During this time span over four million illegally imported and counterfeit Lipitor tablets, valued at over $12 million dollars, was distributed throughout the United States and purchased by unwitting consumers in the United States. In July of 2003, FERNANDEZ fled the United States and was last detected in Barcelona, Spain. FERNANDEZ has a 1995 federal conviction for cocaine trafficking. He received a prison sentence of 85 months.

Also Known As:

Jose Garcia, Jose Enrique Garcia, Armando Perez, Pastor Vento

Date and Place of Birth:

28 June 1959 — Havana, Cuba

Report Fugitive

Nuritsa GRIGORYAN

Summary of OCI Investigation:

Nuritsa GRIGORYAN was an unlicensed medical practitioner and wrote bogus prescriptions using an American doctor’s name and license number, and had close relationships with pharmacies and a fraudulent drug wholesale company that were used to funnel prescription drugs back to the pharmacies participating in the scheme. GRIGORYAN generated thousands of prescriptions for identify theft victims, such as elderly beneficiaries of Medicare or Medicaid, military veterans who were also recruited from drug rehabilitation programs, and the homeless. Members of the conspiracy created or doctored patient files to make it falsely appear the drugs were necessary and the patients were legitimately treated. After the prescriptions were filled at pharmacies and paid for by Medicare and Medicaid, they were sold on the black market and redistributed to pharmacies, where the drugs would be subject to new claims made to Medicare and Medicaid as though they were new bottles of drugs.

GRIGORYAN was convicted, via jury trial, on February 18, 2014 of five felonies relating to the adulteration of the pharmaceuticals. She was scheduled to be sentenced in June 2014 and was facing 35 years’ incarceration. On February 24, 2014, GRIGORYAN unlawfully removed her court ordered ankle bracelet and fled. GRIGORYAN obtained another Armenian passport from the Armenian Consulate in Glendale, CA.

Also Known As:

“Nora” GRIGORYAN

Date and Place of Birth:

7 February 1955 — Yerevan, Armenia

Report Fugitive

Hadi Mo GHANDOUR

Summary of OCI Investigation:

GHANDOUR distributed mislabeled and unapproved new drugs, counterfeit human growth hormone and controlled drugs to other distributors throughout the United States. As part of the scheme, GHANDOUR sold 7,938 units of Tiratricol, a potentially life threatening drug producing heart attacks and strokes, in nine months. Further, GHANDOUR purchased insulin vials, graphics for the lot numbers and expiration dates, along with a labelling machine, and mislabeled the vials of the insulin as human growth hormone.

On 9 March 2004, GHANDOUR pleaded guilty to three counts in an indictment before a United States Magistrate Judge for the Western District of Texas. Following his plea, GHANDOUR was allowed to remain on bail until his sentencing date, which was scheduled in the United States District Court for 25 May 2004. The court allowed GHANDOUR to travel to California for his business and then to Florida to visit his family. He was to return to Austin, Texas, on 26 March 2004, and report to officers the following morning. GHANDOUR failed to report as directed and efforts to locate and/or contact him have been unsuccessful.

Date and Place of Birth:

13 February 1971 — Lebanon

Report Fugitive

Cellou JUMAINE

Summary of OCI Investigation:

From between August 2006 and April 2007, Cellou JUMAINE and co-conspirator Alpha Yaya Jalloh were principals of the Fatala Corporation based in New York, which imported approximately 990,000 tubes of counterfeit Colgate toothpaste into the U.S. from China. JUMAINE and Jalloh knew the imported toothpaste was not a genuine Colgate product, and intended to sell it with counterfeit Colgate marks to confuse and deceive customers. Most of the toothpaste contained either no fluoride or significantly less fluoride than that which is found in genuine Colgate toothpaste. In addition, some of the toothpaste contained harmful substances, such as Bacillus bacteria, and diethylene glycol, which is a chemical toxic to humans. The toothpaste contained in all of the shipments was resold by Fatala Corporation to customers in New York and elsewhere.

Also Known As:

Jumaine CELLOU; Cellou B DIALLO

Date and Place of Birth:

02 May 1965 – Burundi

Additional Information:

JUMAINE may currently reside in the Anta neighborhood of the Matoto commune in Conakry, Guinea

Report Fugitive

Abigail BRIDGMON

Summary of OCI Investigation:

From June 2008 to September 2009, in the Central District of California and elsewhere, Abigail BRIDGMON and others used counterfeit markings to sell counterfeit pharmaceuticals over the Internet, including pills that appeared to be OxyContin, Cialis, Viagra, Levitra, Valium, and human growth hormones. BRIDGMON and others recruited individuals as drop shippers to help distribute the counterfeit pharmaceutical drugs throughout the U.S. to customers who ordered the drugs over the Internet. On 7 occasions, BRIDGMON and others caused parcels containing a total of approximately 3,187 counterfeit pharmaceutical drugs to be sent to a drop shipper in California who would then distribute the drugs to customers. In total, the estimated retail value of the counterfeit products shipped to California was approximately $123,000 USD.

Also Known As:

Abigail Miranda BRIDGMON; Tricia LING

Date and Place of Birth:

04 May 1978 - Angeles City, Philippines

Report Fugitive

Bo JIANG

Summary of OCI Investigation:

JIANG is believed to be the owner/operator of Hua Shun Development Ltd in Auckland, New Zealand, and Shiboliang Foods in China.

From May 2008 to September 2009, in the Central District of California and elsewhere, Bo JIANG and others sold counterfeit pharmaceuticals over the Internet, including OxyContin, Cialis, Viagra, Levitra, Valium, and human growth hormones. Without the proper license, JIANG imported prescription drugs into the U.S., and then recruited and instructed individuals to sell and distribute the counterfeit pharmaceuticals. On at least one occasion, JIANG imported 237 counterfeit pills into the U.S. and, caused 20 packages of counterfeit pharmaceuticals to be shipped within the U.S. On 29 occasions, JIANG and others shipped approximately 17,022 counterfeit pharmaceutical drugs to be distributed to customers in California. The estimated retail value of the counterfeit pharmaceuticals JIANG and others shipped to a customer in California was approximately $123,000 USD.

Also Known As:

Bob JIANG

Date and Place of Birth:

07 June 1978 - Shandong, China

Report Fugitive

Stephen Mark VAN ROOYEN

Summary of OCI Investigation:

Between spring 2002 and March 2006, in the Northern District of Georgia and elsewhere, Stephen VAN ROOYEN and Laura Brown operated a business named Biomark International, (Biomark), and sold stem cells and stem cell injections to persons suffering from Amyotrophic Lateral Sclerosis (ALS or "Lou Gehrig’s Disease"), Multiple Sclerosis, and other chronic diseases. VAN ROOYEN and Brown claimed that their customersÂ’ diseases could be treated or cured through the use and injection of stem cells that were derived from umbilical cord blood. VAN ROOYEN and Brown charged customers between $10,000 and $32,000 USD for each treatment. VAN ROOYEN and Brown injected each customer in the abdomen with 1.5 million stem cells regardless of their disease. The stem cells acquired by VAN ROOYEN and Brown were solely intended for use in laboratory research on animals and were never intended to be used on humans. VAN ROOYEN and Brown misled their customers by convincing them that the treatments would cure their diseases. VAN ROOYEN and Brown received at least $1.2 million USD in proceeds from this scheme, which they took from Biomark and transferred to their own personal joint bank account.

Also Known As:

BCARLISLE Sebastian; Mark DEHAVILLAN; Stephen Mark Van ROOYEN; Steve V ROOYEN; Stephen VAN ROOYEN; Steve VAN ROOYEN; Stephen VANROOYEN; Stephen Mark VANROOYEN

Date and Place of Birth:

16 January 1962-Capetown, South Africa